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The genetic basis of variation in complex traits remains poorly understood, and few genes underlying variation have
been identified. Previous work identified a quantitative trait locus (QTL) responsible for much of the response to
selection on growth in mice, effecting a change in body mass of approximately 20%. By fine-mapping, we have
resolved the location of this QTL to a 660-kb region containing only two genes of known function, Gpc3 and Gpc4, and
two other putative genes of unknown function. There are no non-synonymous polymorphisms in any of these genes,
indicating that the QTL affects gene regulation. Mice carrying the high-growth QTL allele have approximately 15%
lower Gpc3 mRNA expression in kidney and liver, whereas expression differences at Gpc4 are non-significant.
Expression profiles of the two other genes within the region are inconsistent with a factor responsible for a general
effect on growth. Polymorphisms in the 39 untranslated region of Gpc3 are strong candidates for the causal sequence
variation. Gpc3 loss-of-function mutations in humans and mice cause overgrowth and developmental abnormalities.
However, no deleterious side-effects were detected in our mice, indicating that genes involved in Mendelian diseases
also contribute to complex trait variation. Furthermore, these findings show that small changes in gene expression can
have substantial phenotypic effects.
Citation: Oliver F, Christians JK, Liu X, Rhind S, Verma V, et al. (2005) Regulatory variation at glypican-3 underlies a major growth QTL in mice. PLoS Biol 3(5): e135.
Introduction
Understanding the mechanisms that underlie phenotypic
variation within species is crucial to addressing fundamental
issues in medicine, agriculture, and evolutionary biology [1].
Identifying genes that contribute to variation in traits
affected by multiple genetic and environmental factors has
proven extremely difﬁcult [2], although the molecular basis of
a few quantitative trait loci (QTLs) has been elucidated [3,4,5].
Despite these successes, several general questions remain,
such as whether genes involved in Mendelian disorders also
contribute to complex trait variation [6], and the extent to
which coding sequence versus regulatory variation is respon-
sible for complex trait variation. In cases where there is
heritable variation in gene expression, it is not clear what
magnitude of difference is sufﬁcient to contribute to
phenotypic variation without substantial deleterious effects.
These issues are particularly relevant to the further identi-
ﬁcation of genes responsible for complex trait variation.
Numerous studies use expression microarrays to identify
genes underlying trait variation [7,8,9,10], and yet such
approaches will not detect coding sequence variation or
subtle differences in expression.
An archetypal model for complex trait variation is body size,
but with the exception of a few Mendelian mutations [11,12],
no gene contributing to quantitative variation in this trait has
been identiﬁed in animals. In previous work that examined
lines of mice divergently selected for body size, we showed that
much of the selection response is due to a large-effect QTL on
chromosome (Chr) X that causes an approximately 20% dif-
ference in growth rate between homozygotes [13,14] and
explains 14% of the phenotypic variance at 6 wk in an F2 cross
between the selection lines [15]. A large X-linked effect was
observed in replicate selection lines derived independently
from the same base population [13], indicating that the QTL is
not due to a mutation that occurred during the selection
process. Rather, it is due to variation segregating within the
initial population, which was derived from a cross between two
inbred and one outbred strains. This scenario contrasts with
the ‘‘high growth’’ mutation (hg), which arose during selection
for increased growth rate in a different set of selection lines
[16] and resulted from a disruption of Socs2 (suppressor of cytokine
signalling 2), which eliminated the expression of this gene [12].
To determine the molecular basis of the X-linked QTL, we
ﬁne-mapped the QTL by progeny testing, searched for
sequence polymorphisms in annotated coding regions, and
examined the expression of all genes within the target region.
Results/Discussion
Fine-Mapping
The QTL had previously been mapped to a region of
approximately 2 cM, or 2.6 Mb [14]. By further progeny
testing, we reﬁned the location of the QTL to an approx-
imately 660-kb region (Figure 1). The entire effect of the QTL
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is attributable to this region, as demonstrated by three
recombinant families: families 103 and 105 segregate for the
QTL region and for the phenotypic effect of the QTL,
whereas family 101 does not segregate for either (Figure 1;
Table 1). In both sexes, the differences in effect size between
families 103 and 101 and between families 105 and 101 are
signiﬁcant (p , 0.02 in all cases), whereas the differences
between families 103 and 105 are not signiﬁcant (p . 0.2 in
both cases). Thus, in contrast to previous studies that have
either found QTLs to be composed of multiple QTLs (e.g.,
[17,18]), or have lacked the statistical power to dissect a single
QTL, this large-effect QTL is caused entirely by one small
chromosomal region.
Further ﬁne-mapping of the QTL has not been possible
because the target region appears to be located in a
recombination ‘‘cold spot’’ (Figure 1). There is substantial
heterogeneity in the recombination rate within the region,
roughly similar in magnitude to variation observed in
humans [19], although the cold spot may be unusually wide.
Genes within QTL Region
The QTL region contains four genes according to the
Ensembl database [20], and function is known for only two of
these: Gpc3 and Gpc4 (Figure 1). Both of these genes encode
members of the glypican family of membrane-bound heparin
sulphate proteoglycans that are involved in morphogenesis
and growth regulation [21]. Loss-of-function mutations in
Gpc3 lead to Simpson–Golabi–Behmel syndrome in humans, a
disorder with numerous phenotypic effects, including over-
growth, skeletal and renal developmental abnormalities, an
increased frequency of embryonic cancers, and neonatal
mortality [22,23,24]. Gpc3 knock-out mice show similar
phenotypes, including increased body mass, renal dysplasias,
and increased perinatal mortality [25]. In contrast, no obvious
phenotypes are seen in Gpc4 knock-out mice [26].
DNA sequencing revealed no differences in coding
sequence between the high- and low-line QTL alleles at
Gpc3, Gpc4, or Q8C9S7, one of the genes of unknown
function. In the other gene of unknown function, Q9D9G4,
there was one synonymous single nucleotide polymorphism
(Table S1).
Quantitative Measurement of Expression of Gpc3
and Gpc4
The lack of non-synonymous differences indicates that the
effect of the QTL must be due to regulatory variation. We
therefore measured mRNA transcript levels in tissues of
congenic mice from litters in which the QTL segregated.
Newborns were examined, since the effect of the QTL on
neonatal body weight is as large as that in adults [27].
Transcript levels of Gpc3 and Gpc4 were examined in kidney
and liver, since both genes are expressed in these tissues in
mice [28], and kidney abnormalities are often observed inGpc3
loss-of-function mutations in humans and mice [22,23,25].
Mice with the high-line allele showed 15% lower expression
of Gpc3 in liver and kidney (p = 0.017 and p = 0.012,
respectively, from a general linear model ﬁtting effects of
genotype, sex, and litter; Figure 2), whereas the differences in
transcript levels for Gpc4 were non-signiﬁcant (p = 0.08 and
p = 0.74, respectively), and the trends varied in direction
between tissues (Figure 2; Table S2). Transcript levels of Gpc3
and Gpc4 were adjusted by dividing by b-actin levels;
correcting for b-actin by including it as a co-variate in the
Figure 1. QTL Region
At the top is shown the extent of Chr X segregating in three
recombinant families. The horizontal grey bars indicate the regions
known to segregate, while the error bars show the uncertainty in the
location of recombination. Black bars indicate genes within the
QTL region according to the Ensembl database [20]. Below is a LOD
score plot for body mass at 6 wk in entire progeny test population
(n = 1,909). Triangles indicate the locations of markers. At the
bottom, recombination rates are shown for the intervals delimited
by diamonds (the Chr X average is 0.40 cM/Mb [40]).
DOI: 10.1371/journal.pbio.0030135.g001
Table 1. Body Mass at 6 Wk of Age in Families 103 and 105, Which Segregate for the QTL Region, and Family 101, Which Does Not
Family Females Males Total Sample Size
Homozygous Low Heterozygous High/Low Differencea Hemizygous Low Hemizygous High Differencea
Family 101 13.8 6 0.3 13.9 6 0.2 0.1 6 0.4 16.9 6 0.3 16.1 6 0.3 0.8 6 0.4 106
Family 103 13.1 6 0.2 14.7 6 0.14 1.6 6 0.2 * 16.1 6 0.2 19.1 6 0.2 3.0 6 0.3 * 194
Family 105 13.8 6 0.2 15.0 6 0.2 1.2 6 0.3 * 16.0 6 0.2 18.8 6 0.2 2.8 6 0.3 * 183
Values are least squares means 6 standard errors from a general linear model including family, litter nested within family, genotype, and family-by-genotype interaction.
a An asterisk indicates that the difference between genotypes within a family is significant (p , 0.0001); no asterisk indicates p . 0.05.
DOI: 10.1371/journal.pbio.0030135.t001
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model yielded qualitatively similar results. The lower level of
expression of Gpc3 in mice with the high body mass QTL
allele is consistent with the overgrowth seen in Gpc3 knock-
out mice [25].
Given the phenotypic effects of the QTL (Table 1), we
would expect the difference in Gpc3 expression between
hemizygous low-allele males and hemizygous high-allele males
to be greater than the difference between homozygous low-
allele females and heterozygous females. Although there
appeared to be some indication of sex-speciﬁc differences
in Gpc3 expression in liver (Table S2), this was largely due to a
marginally non-signiﬁcant sex-by-genotype interaction in b-
actin levels used to normalise Gpc3 expression (p = 0.06),
which generated the pattern shown in Table S2; untrans-
formed liver Gpc3 levels did not show a signiﬁcant sex-by-
genotype interaction (p = 0.13). The lack of signiﬁcant sex-
speciﬁc differences in Gpc3 expression is likely due to low
statistical power to detect interactions.
Expression Profiling of Genes of Unknown Function
To examine whether the two genes of unknown function
might contribute to the effect of the QTL, we examined their
expression using a 24-tissue gene-expression panel. Q9D9G4
(also known as 1700080O16) was originally identiﬁed in adult
male testis cDNA [20], and we observed clear expression in
this tissue, as well as very low levels of expression in muscle,
lung, and small intestine; no expression was detected in
embryos. Others have also found much greater expression of
this gene in testis than in any other tissue in a 61-tissue panel
[29] and in a 55-tissue panel [30].
Q8C9S7 (also known as A630012P03) was originally identi-
ﬁed in 3-d neonate thymus cDNA [20], and while we were able
to detect very low levels of expression in the thymus of 3-d-
old mice, we were unable to detect its expression in any adult
tissue or embryonic stage using the commercially available
expression panel. Q8C9S7 could not be found and/or there
was inconsistent annotation in other expression panels
[29,30]. Furthermore, this gene appears to be homologous
to an annotated human pseudogene (AF003529.2) [20].
Because genes of unknown function with restricted patterns
of expression did not present strong candidates for the
causative factor underlying a QTL with a general effect on
growth rate in both sexes, we did not pursue these two genes
further.
Expression of a Gene Downstream from Gpc3
To investigate the pathways through which Gpc3 might
exert its effect, we examined the expression of Smad6 (mothers
against decapentaplegic homolog 6); Gpc3 has been shown to affect
BMP-7 (Bone morphogenic protein 7) signalling [31], which in
turn promotes the expression of Smad6 [32]. However, Smad6
transcript levels did not differ signiﬁcantly between geno-
types in newborn liver or kidney (data not shown), suggesting
that Gpc3 exerts its effect through a different pathway.
Glypican-3, the protein encoded by Gpc3, has been shown to
bind to FGF-2 (ﬁbroblast growth factor 2) [32,33]. Therefore,
the lower Gpc3 levels in mice with the high-line allele may
lead to higher levels of unbound FGF-2 or other growth
factors that may promote growth. However, insulin-like
growth factors do not appear to be targets of Gpc3 binding
[33,34].
Polymorphisms in Non-Coding DNA Adjacent to Gpc3
To identify candidate polymorphisms that might be
responsible for the difference in Gpc3 transcript levels, we
sequenced the 59 and 39 untranslated regions (UTRs), 2,876 bp
upstream from the 59 UTR of Gpc3 (including its promoter
region [35]), 1,724 bp downstream of the 39UTR, the ﬁrst 1,048
bp of intron 1, as well as 3,377 bp of other regions of intron 1
that were identiﬁed as having high conservation with human.
These are the non-coding regions near genes that show the
highest levels of sequence conservation in rodents [36]. The
only sequence differences between the high- and low-line-
derived regions were three mononucleotide repeat poly-
morphisms (one in the ﬁrst intron of Gpc3 and two in the
39 UTR), two dinucleotide repeat polymorphisms downstream
from Gpc3, and a single nucleotide polymorphism 1,455 bp
downstream of the 39 UTR (see Table S1). This low level of
polymorphism is consistent with previous ﬁndings [14] and a
low frequency of microsatellite polymorphism between the
lines. The 39 UTR polymorphisms present strong candidate
polymorphisms for the differential expression of Gpc3, since
39 UTRs are known to play a role in mRNA stability [37,38].
For instance, the 39 UTR of dally, a Drosophila member of the
glypican family, affects the mRNA levels of this gene [39].
Furthermore, the polymorphic segments of the 39 UTR show
high conservation across mammals (Figure 3A and B). A
BLAST search of a 450-bp region surrounding the down-
stream single nucleotide polymorphism yielded hits in the
region of Gpc3 in both human and rat, and indicated that this
base pair is also conserved across these species (Figure 3C).
While the 39UTR polymorphisms are promising candidates, it
should be noted that the causative polymorphism(s) may be
located further upstream or downstream than was sequenced,
or in an intron (e.g., [4]).
Pleiotropic Effects of Altered Gpc3 Expression
Knock-out mutations of Gpc3 generate a range of
pathological phenotypes, and it might be expected that
QTL-associated regulatory variation at Gpc3 would generate
milder forms of these pleiotropic effects. We therefore
conducted post-mortem and histological analyses on a
sample of 34 age- and sex-matched individuals. Some of
the most prominent pathological conditions of Gpc3-
Figure 2. Transcript Levels of Gpc3 and Gpc4 (Divided By b-actin)
Expression was measured in newborn liver and kidney in homozygous
low-allele females and hemizygous low-allele males (black bars) and in
heterozygous females and hemizygous high-allele males (grey bars).
Data are from 23 low-allele mice and 24 high-allele males/hetero-
zygous females, and values are least squares means (6 23 standard
error); *, p , 0.05.
DOI: 10.1371/journal.pbio.0030135.g002
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deﬁcient mice are cystic and dysplastic kidneys, imperforate
vaginas leading to swelling of the perineum and ﬂuid-ﬁlled
uteri, and susceptibility to respiratory infections [25].
However, there was no evidence of cystic medullary
dysplasia resembling that seen in the Gpc3-deﬁcient pheno-
type in mice carrying the high- or low-line allele. Although a
range of incidental and pathological features were recorded
(Table S3), no phenotype was consistently associated with
either genotype.
Since Gpc3-deﬁcient mice have a reduced survival proba-
bility to weaning [25], we compared the numbers of high- and
low-genotype mice surviving to weaning age in segregating
litters. There is no evidence of a signiﬁcant effect of genotype
on numbers of high- and low-allele mice at weaning (512 and
554, respectively; v21 = 1.65; p= 0.2). For litter size, congenic
females homozygous for the high-line QTL allele have
somewhat higher performance than females homozygous for
the low-line allele (mean 6 standard error, 5.38 6 0.22 versus
4.78 6 0.18, respectively; t198 = 2.13; p = 0.03).
Conclusions
In this study, we ﬁne-mapped a growth QTL to a region
containing only two genes of known function, found no
coding sequence variation in these two genes, and demon-
strated signiﬁcant differences in the transcript levels of Gpc3.
The phenotypic and expression differences between QTL
genotypes are consistent with known loss-of-function muta-
tions and knock-out phenotypes (i.e., reduced or absent Gpc3
expression leads to increased body size). These results
underscore the potential impact of relatively small changes
in expression levels on phenotype.
Our results show that a gene underlying a Mendelian
disease in humans can contribute to quantitative variation in
mice. Unlike loss-of-function mutations, allelic variation in
Gpc3 had no pathological side-effects that we were able to
detect; it affected growth rate only, and did so at all ages and
in all tissues that we studied [27]. This work provides further
evidence that the glypicans are involved in normal growth
processes in addition to their role in Simpson–Golabi–
Behmel syndrome and a variety of cancers [32].
Materials and Methods
Experimental mice. The inbred low line and a congenic for a high-
line segment of Chr X were described previously [14]. We continued
marker-assisted backcrossing to the low line to produce an interval-
speciﬁc congenic strain containing a 14-cM segment of Chr X from
the high line on the low-line background, with a contribution from
high-line autosomes of less than 0.1%. The mice used in this study
were at backcross generation 10–12. All experiments were carried out
in accordance with U.K. Home Ofﬁce regulations.
Progeny testing. Heterozygous females from the interval-speciﬁc
congenic strain were crossed with low-line males, and mice
recombinant between DXMit226 and DXMit68 were used for progeny
testing. Recombinant males and females were crossed with low-line
mice to produce families that segregated for the recombinant
segment. Body weights at 6 wk of age from the progeny were
recorded and ﬂanking markers genotyped. Further genotyping using
a range of microsatellite markers established the recombination
breakpoints; microsatellite primer sequences are available in Table
S4. PCR genotyping was carried out on DNA extracted from ear clip
or tail clip samples [14].
Maximum likelihood analysis. The marker allelic states and
phenotypes of the progeny test dataset were analysed by maximum
likelihood interval mapping [14]. Brieﬂy, each recombination event
was assumed to have been replicated across litters, and the
phenotypic and ﬂanking marker data at a given chromosomal
position were used to estimate a hemizygous effect in males;
homozygous and heterozygous effects in females; normally distrib-
uted litter effects; and effects for litter size, parity, and sex.
Figure 3. Polymorphisms between High- and Low-Line-Derived Chr X
(A) 80 bp from the stop codon of Gpc3 in the 39 UTR.
(B) 332 bp from the stop codon of Gpc3 in the 39 UTR.
(C) 1,455 bp downstream of Gpc3.
Sequence in common with reference mouse sequence [20] is denoted by dots.
DOI: 10.1371/journal.pbio.0030135.g003
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Likelihood ratio for the model with a QTL relative to that for the
reduced model with no QTL was calculated every 0.1 cM in the region
of interest, and converted to a LOD score. There were 937 males and
972 females in the dataset.
Post-mortem and histology analysis. A total of 34 mice, matched
for genotype and sex, were sacriﬁced between 8 and 16 wk of age and
immediately underwent a comprehensive post-mortem and histolog-
ical investigation. Tissue samples were ﬁxed in 10% phosphate-
buffered formalin and processed routinely. Sections were cut at 4 lm
and stained with haematoxylin and eosin. Samples of all major organ
systems were examined (urinary, cardiovascular, respiratory, alimen-
tary, endocrine, reproductive, haemolymphatic, integumentary,
musculoskeletal, and central nervous systems). Standard histopatho-
logical analysis was carried out and morphologic abnormalities
recorded (see Table S3).
DNA sequencing. Sequencing was carried out in forward and
reverse directions using DYEnamic ET Terminator Cycle Sequenc-
ing Kits (Amersham Biosciences, Little Chalfont, United Kingdom)
on an ABI Prism 3730 DNA Analyzer (Applied Biosystems, Foster
City, California, United States) according to manufacturer’s in-
structions. Sequencing primer sequences are shown in Table S5.
Gpc3 is a large gene with almost 340 kb of intronic sequence. We
therefore sequenced only a subset of the intronic regions, focusing
on regions with high sequence conservation between mouse and
human to increase the likelihood of ﬁnding functional sequences.
Conserved regions were identiﬁed using the ‘‘Detailed view’’ of
ContigView at the Ensembl Web site [20] (displayed using the
‘‘Compara’’ menu).
RT-PCR. Transcript levels were examined in kidney and liver from
47 newborn mice from seven litters that were segregating for the QTL
region (23 low-allele mice and 24 high-allele males or heterozygous
females). Tissue samples were collected into RNAlater solution
(Qiagen, Valencia, California, United States) and stored at20 8C until
required. Total RNA was isolated from tissue using Qiashredder
homogenisers (Qiagen) and RNAEasy Extraction kits (Qiagen) accord-
ing to manufacturer’s instructions. We performed RT-PCR using One
Step RT-PCR kits (Qiagen) with the addition of RNAsin RNase
inhibitor (Promega, Madison, Wisconsin, United States). Reaction
conditions were optimised for each gene tested and for each tissue type
to ensure the PCR reactions did not reach saturation. Speciﬁcally, we
determined the number of PCR cycles and starting RNA concentration
such that the amount of product varied linearly with RNA concen-
tration. RT-PCR primer sequences are provided in Table S6, and RT-
PCR conditions are listed in Table S7. To check for DNA contami-
nation, 5 ll of each RT-PCR product was run out on a 1% agarose gel.
Although no splice variants of Gpc3 or Gpc4 are known, we designed
three primer pairs for each gene (for Gpc3, these spanned introns 2, 3,
and 7; for Gpc4, these spanned introns 1, 3, and 8). For both genes, all
three primer pairs yielded products of the expected size from ‘‘high’’
genotype RNA. Furthermore, because we sequenced the coding region
using cDNA (see Table S5), we know that the entire genes are expressed
for both alleles. Quantitative measurement of expression levels was
performed using only one of the primer pairs per gene (see Table S6).
RT-PCR product quantiﬁcation by DHPLC. RT-PCR products were
quantiﬁed using a WAVE denaturing high-pressure liquid chroma-
tography instrument at an oven temperature of 50 8C.We sampled 5 ll
of each RT-PCR product on a DNASep column. Samples were eluted
from the column using an acetonitrile gradient in a 0.1 M triethyl-
amine acetate buffer (pH 7), at a constant ﬂow rate of 0.9 ml min1.
The gradient was created by mixing eluent A (0.1 M triethylamine
acetate and 0.1 M tetrasodium EDTA) and eluent B (25% acetonitrile
in 0.1 M triethylamine acetate) according to the manufacturer’s
speciﬁcations (Transgenomic, Omaha, Nebraska, United States). Each
litter of mice was measured for all three genes in one assay to
eliminate variation due to differences between runs. Transcript levels
of Gpc3 and Gpc4 were expressed relative to that of b-actin by dividing
the amount of Gpc3 or Gpc4 product by that of b-actin. Because the RT-
PCR and quantiﬁcation provided only an index of transcript levels,
these are in arbitrary units. All samples were analysed in triplicate and
the average within-assay coefﬁcient of variation was less than 5%.
Expression of genes of unknown function. The tissue distribution
patterns of expression of Q8C9S7 and Q9D9G4 were surveyed using
mouse Rapid-Scan Gene Expression panels (OriGene Technologies,
Rockville, Maryland, United States; MSCB101) that included cDNA
from brain, heart, kidney, spleen, thymus, liver, stomach, small
intestine, muscle, lung, testis, skin, adrenal gland, pancreas, uterus,
prostate gland, breast (virgin, pregnant, lactating, and involuting),
and embryo (e8.5, e9.5, e12.5, and e19). The kits were used in
accordance with manufacturer’s instructions using an initial activa-
tion of 3 min at 94 8C; followed by 35 cycles of 30 s at 94 8C, 30 s at
55 8C, and 2 min at 72 8C; and a ﬁnal extension of 5 min at 72 8C
(primer sequences are provided in Table S6).
Supporting Information
Table S1. Sequence Polymorphisms between the High-Growth Line,
Low-Growth Line, and Reference Mouse Sequence [20]
Found at DOI: 10.1371/journal.pbio.0030135.st001 (41 KB DOC).
Table S2. Transcript Levels (Expressed as Ratio of b-actin Levels) in
Newborn Mice from Litters Segregating for the QTL
Values are least squares means (LSM) and standard errors (SE) from a
general linear model including litter, sex, genotype, and sex-by-
genotype interaction.
Found at DOI: 10.1371/journal.pbio.0030135.st002 (40 KB DOC).
Table S3. Summary of Post-Mortem and Histological Investigations
All females were homozygous high or low (i.e., not from segregating
litters as in the expression and mapping studies).
Found at DOI: 10.1371/journal.pbio.0030135.st003 (65 KB DOC).
Table S4. Microsatellite Primer Sequences
Physical positions are from Ensembl Build 24.33.1 [20].
Found at DOI: 10.1371/journal.pbio.0030135.st004 (56 KB DOC).
Table S5. Sequencing Primer Sequences
Primers for Gpc3 and Gpc4 were designed to span introns and were
used to sequence cDNA. All other primers were designed for direct
sequencing of genomic DNA.
Found at DOI: 10.1371/journal.pbio.0030135.st005 (79 KB DOC).
Table S6. RT-PCR Primer Sequences
Found at DOI: 10.1371/journal.pbio.0030135.st006 (32 KB DOC).
Table S7. RT-PCR Conditions
In all cases, the RT-PCR consisted of an initial reverse transcription
of 30 min at 50 8C; initial activation of 15 min at 95 8C; a variable
number of cycles of 1 min at 94 8C, 1 min at 55 8C, and 1 min at 72 8C;
and a ﬁnal extension of 10 min at 72 8C.
Found at DOI: 10.1371/journal.pbio.0030135.st007 (35 KB DOC).
Accession Numbers
The LocusLink (http://www.ncbi.nlm.nih.gov/LocusLink/) accession
numbers for the genes and gene products discussed in this paper
are b-actin (LocusLink ID 11461), BMP-7 (LocusLink ID 12162), dally
(LocusLink ID 39013), FGF-2 (LocusLink ID 14173), Gpc3 (LocusLink
ID 14734), Gpc4 (LocusLink ID 14735), Smad6 (LocusLink ID 17130),
and Socs2 (LocusLink ID 216233). The Vega Gene ID (http://
www.ensembl.org/) for human pseudogene AF003529.2 is OT-
THUMG00000022447.
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